234 related articles for article (PubMed ID: 25252121)
1. Mechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model.
Xu Y; Zhuang H; Han S; Liu C; Wang H; Mathews CE; Massini J; Yang L; Reeves WH
Arthritis Rheumatol; 2015 Jan; 67(1):225-37. PubMed ID: 25252121
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 7-stimulated tumor necrosis factor α causes bone marrow damage in systemic lupus erythematosus.
Zhuang H; Han S; Xu Y; Li Y; Wang H; Yang LJ; Reeves WH
Arthritis Rheumatol; 2014 Jan; 66(1):140-51. PubMed ID: 24449581
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus.
Xu Y; Lee PY; Li Y; Liu C; Zhuang H; Han S; Nacionales DC; Weinstein J; Mathews CE; Moldawer LL; Li SW; Satoh M; Yang LJ; Reeves WH
J Immunol; 2012 Apr; 188(8):4113-21. PubMed ID: 22422888
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
[TBL] [Abstract][Full Text] [Related]
5. X-linked immunodeficient mice spontaneously produce lupus-related anti-RNA helicase A autoantibodies, but are resistant to pristane-induced lupus.
Satoh M; Mizutani A; Behney KM; Kuroda Y; Akaogi J; Yoshida H; Nacionales DC; Hirakata M; Ono N; Reeves WH
Int Immunol; 2003 Sep; 15(9):1117-24. PubMed ID: 12917264
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of IkappaB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells.
Miyamoto R; Ito T; Nomura S; Amakawa R; Amuro H; Katashiba Y; Ogata M; Murakami N; Shimamoto K; Yamazaki C; Hoshino K; Kaisho T; Fukuhara S
Arthritis Res Ther; 2010; 12(3):R87. PubMed ID: 20470398
[TBL] [Abstract][Full Text] [Related]
7. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
[TBL] [Abstract][Full Text] [Related]
8. Interferon Lambda Regulates Cellular and Humoral Immunity in Pristane-Induced Lupus.
Aschman T; Schaffer S; Biniaris Georgallis SI; Triantafyllopoulou A; Staeheli P; Voll RE
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769174
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid dendritic cell distribution and maturation are altered in lupus prone mice prior to the onset of clinical disease.
Scott JL; Wirth JR; EuDaly JG; Gilkeson GS; Cunningham MA
Clin Immunol; 2017 Feb; 175():109-114. PubMed ID: 28041989
[TBL] [Abstract][Full Text] [Related]
10. Monocytes from Irf5-/- mice have an intrinsic defect in their response to pristane-induced lupus.
Yang L; Feng D; Bi X; Stone RC; Barnes BJ
J Immunol; 2012 Oct; 189(7):3741-50. PubMed ID: 22933628
[TBL] [Abstract][Full Text] [Related]
11. Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model.
Tumurkhuu G; Chen S; Montano EN; Ercan Laguna D; De Los Santos G; Yu JM; Lane M; Yamashita M; Markman JL; Blanco LP; Kaplan MJ; Shimada K; Crother TR; Ishimori M; Wallace DJ; Jefferies CA; Arditi M
Front Immunol; 2020; 11():554725. PubMed ID: 33072095
[TBL] [Abstract][Full Text] [Related]
12. A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM.
Zhuang H; Han S; Li Y; Kienhöfer D; Lee P; Shumyak S; Meyerholz R; Rosadzinski K; Rosner D; Chan A; Xu Y; Segal M; Sobel E; Yang LJ; Hoffmann MH; Reeves WH
Arthritis Rheumatol; 2016 Dec; 68(12):2917-2928. PubMed ID: 27274010
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus.
Sacre K; Criswell LA; McCune JM
Arthritis Res Ther; 2012 Jun; 14(3):R155. PubMed ID: 22734582
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of autoantibody production in pristane-induced murine lupus.
Han S; Zhuang H; Xu Y; Lee P; Li Y; Wilson JC; Vidal O; Choi HS; Sun Y; Yang LJ; Reeves WH
Arthritis Res Ther; 2015 Dec; 17():384. PubMed ID: 26717913
[TBL] [Abstract][Full Text] [Related]
15. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
[TBL] [Abstract][Full Text] [Related]
16. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.
Thibault DL; Graham KL; Lee LY; Balboni I; Hertzog PJ; Utz PJ
Arthritis Res Ther; 2009; 11(4):R112. PubMed ID: 19624844
[TBL] [Abstract][Full Text] [Related]
17. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
Summers SA; Odobasic D; Khouri MB; Steinmetz OM; Yang Y; Holdsworth SR; Kitching AR
Clin Exp Immunol; 2014 Jun; 176(3):341-50. PubMed ID: 24528105
[TBL] [Abstract][Full Text] [Related]
18. C1q Modulates the Response to TLR7 Stimulation by Pristane-Primed Macrophages: Implications for Pristane-Induced Lupus.
Carlucci F; Ishaque A; Ling GS; Szajna M; Sandison A; Donatien P; Cook HT; Botto M
J Immunol; 2016 Feb; 196(4):1488-94. PubMed ID: 26773156
[TBL] [Abstract][Full Text] [Related]
19. Estrogen Receptor α Deficiency Modulates TLR Ligand-Mediated PDC-TREM Expression in Plasmacytoid Dendritic Cells in Lupus-Prone Mice.
Scott JL; Cunningham MA; Naga OS; Wirth JR; Eudaly JG; Gilkeson GS
J Immunol; 2015 Dec; 195(12):5561-71. PubMed ID: 26553076
[TBL] [Abstract][Full Text] [Related]
20. Integrin αvβ3 Limits Cytokine Production by Plasmacytoid Dendritic Cells and Restricts TLR-Driven Autoimmunity.
Lorant AK; Yoshida AE; Gilbertson EA; Chu T; Stefani C; Acharya M; Hamerman JA; Lacy-Hulbert A
J Immunol; 2024 Jun; 212(11):1680-1692. PubMed ID: 38607278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
